China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

Astellas is shifting its investment focus toward more established modalities and later-stage opportunities, its chief ...

Genomics is bringing in a new wave of money from an unlikely group of investors — health systems. More providers are ...

Market OverviewThe Global Carrier Screening Market is a genetic testing process that determines whether an individual carries ...

Through new partnerships with industry leaders, Nvidia aims to help advance practical use cases for AI in healthcare and life ...